Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia - Que, Y A; Lazar, H; Wolff, M (Eur J Clin Microbiol Infect Dis, 2014)
, et al.